Methods: We described a case series of patients experiencing AP while on GLP-1 RAs
Participants taking the highest dose (15 mg) lost an average of 22.5% of their body weight over 72 weeks, compared to 2.4% with placebo
Tirzepitide 2.5mg to address her weight gain was increased to 5mg once weekly, resulting in at least 6570% improvement in her symptoms, including fatigue and cognitive impairment
Natural or synthesised phospholipids, including 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), are commonly utilised owing to their well-defined thermotropic phase transition properties
If you have any questions or concerns about your health plan, Eden connects individuals with a licensed healthcare provider who can evaluate your medical history and determine whether treatment options may be appropriate
You can read more about our medical team by visiting the medical team page or learn more about how we curate content by visiting our editorial process
